Science
Passage Bio Inc (NASDAQ: PASG) Continues To Thrive In 2025, As Its Stock Is Down -20.35% Year-To-Date
During the last session, Passage Bio Inc (NASDAQ:PASG)’s traded shares were 2.95 million, with the beta value of the company hitting 1.62. At the end